BioSpace News Archive

Deciphera Pharmaceuticals, Inc. (NASDAQ:DCPH) today announced financial results for the first quarter ended March 31, 2022, and provided a corporate update.

Orthofix Medical Inc today announced the U.S. Food and Drug Administration (FDA) pre-market approval for the AccelStim ™ bone healing therapy Class III device.

Diffusion Pharmaceuticals Inc. today announced that it received written notice from the Nasdaq Listing Qualifications Staff of the NASDAQ Stock Market LLC (“Nasdaq”) stating that the Company has regained compliance with the Nasdaq minimum bid price.

Bruker Corporation (Nasdaq: BRKR) today announced financial results for its first quarter ended March 31, 2022.

Abeona Therapeutics Inc. today announced the presentation of new preclinical data on AAV204 at the Association for Research and Vision in Ophthalmology (ARVO) Annual Meeting, taking place on May 1-4, 2022 in Denver, CO and virtually on May 11-12, 2022.

ElevateBio, LLC today announced a poster presentation on ElevateBio BaseCamp’s lentiviral vector production platform at the upcoming American Society of Gene and Cell Therapy (ASGCT) 25th Annual Meeting taking place May 16-19, 2022 in Washington, DC.

Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced its financial results for the first quarter ended March 31, 2022.

Vericel Corporation today reported financial results and business highlights for the first quarter ended March 31, 2022.

CRISPR Therapeutics announced that members of its senior management team are scheduled to participate in the 2022 Bank of America Healthcare Conference on Wednesday, May 11, 2022, at 4:40 p.m. PT.

Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a commercial-stage biopharmaceutical company committed to transforming the care of people living with rare genetic diseases of obesity, today announced that David Meeker, M.D., Chair, Chief Executive Officer and President, will participate in a fireside chat at the BofA Securities 2022 Healthcare Conference.